Remote Senior Director, Integrated Planning & Analytics

BioSpace; Kansas; On-site; USD 250,000 - 350,000; Full time

Job summary

BioMarin seeks a Senior Director of Integrated Planning & Analytics to drive enterprise IBP across demand, supply, inventory, capacity, and financial objectives. You will connect Commercial, Clinical, Manufacturing, Quality, Regulatory, Medical, and Finance to enable patient-centric supply decisions.

The role emphasizes building planning capability, leading analytics, and aligning global planning with risk management and portfolio needs in a rare-disease context.

Qualifications

• Bachelor’s degree in Supply Chain, Engineering, Business, Life Sciences, or related field required.
• 12+ years of progressive supply chain or operations leadership in biotech, pharmaceutical, or rare disease environments.

Responsibilities

• IBP Process Ownership in a Rare Disease Environment.
• Own the global IBP framework for rare disease planning across demand, supply, inventory, capacity and financial objectives.
• Establish governance and decision rights for trade-offs.
• Lead structured decision-making in Executive IBP for senior leadership.
• Drive adoption of IBP behaviors across cross-functional teams.
• Lead Data Analytics to support scenario modeling and proactive decision-making.

Skills

IBP

S&OP

Leadership

Strategic thinking

Data analytics

Inventory strategy

Risk management

Change leadership

Executive influence

Education

Bachelor’s degree in Supply Chain, Engineering, Business, Life Sciences, or related field

Master’s degree (MBA, MS, or equivalent)

Tools

ERP systems

Advanced planning systems

Analytics tools

Job description

BioMarin seeks a Senior Director of Integrated Planning & Analytics to drive enterprise IBP across demand, supply, inventory, capacity, and financial objectives. You will connect Commercial, Clinical, Manufacturing, Quality, Regulatory, Medical, and Finance to enable patient-centric supply decisions.

The role emphasizes building planning capability, leading analytics, and aligning global planning with risk management and portfolio needs in a rare-disease context.